GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
8.78126 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, PRKCA, SMAD3, SRC, TEK, TRPV1, XDH |
8.55385 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, TRPV1 |
8.45007 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
7.57464 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TEK, TRPV1, TYR |
7.26348 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
6.87157 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
6.87157 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.87157 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
6.63614 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, HSPA1A, PIM1, PPARA, TYR, XDH |
6.63614 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SLC5A2, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
6.48045 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
6.40638 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
6.40584 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, ALOX12, APP, CDC25B, CHRM1, CSNK2A1, CYP1B1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, PRKCA, SMAD3, SRC, TEK, XDH |
6.37887 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.37887 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.37887 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK |
6.29741 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.29741 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.24025 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.1216 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK |
6.0624 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.01 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.99258 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SLC5A1, SMAD3, SRC, TEK, TRPV1, TYR |
5.94495 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
5.90848 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, RORC, SMAD3, SRC, TRPV1 |
5.73435 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, PTPN1, SRC, TEK, XDH |
5.68548 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
5.65358 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC, TEK |
5.56608 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, FLT3, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, PRKCA, RORC, SMAD3, SRC, TEK, TYR |
5.53047 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, NR3C1, RORC, SRC, TEK, TRPV1, TYR |
5.48001 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AXL, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PRKCA, PTPN1, SRC, TEK, XDH |
5.4611 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.46076 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.44964 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PRKCA, PTPN1, SMAD3, SRC, TEK |
5.44652 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX12, ALOX15, APP, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1 |
5.42366 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.42366 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH |
5.42366 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
5.26467 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.26467 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
5.23502 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, NR3C1, PPARA, SRC, TEK, TRPV1 |
5.20927 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.14929 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
5.14929 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
5.14929 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK |
5.12271 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.06374 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
5.05068 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
5.04254 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
5.03391 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APP, AXL, CYP1A1, CYP1B1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, RORC, SMAD3, SRC, TRPV1 |
5.02951 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR |
4.99334 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
4.91536 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PTPN1, RORC, SMAD3, SRC, TRPV1 |
4.91536 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.91536 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.91536 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, MET, PPARA |
4.90547 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, CDC25B, CHRM5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.85114 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, RORC, SRC, TYR |
4.84538 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.82502 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, CDC25B, CHRM5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.80785 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, HCAR2, HSD11B1, HSD17B1, HSD17B2, PRKCA |
4.76263 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, XDH |
4.67974 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, PRKCA, TEK |
4.61215 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.58958 |
[BP] GO:0040012 |
regulation of locomotion
|
ALOX12, APP, CHRM1, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
4.58438 |
[BP] GO:0030334 |
regulation of cell migration
|
ALOX12, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
4.52074 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SLC5A2, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
4.51548 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, FLT3, MET, PIM1, SRC, TEK, TYR |
4.50862 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.49739 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.39035 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, XDH |
4.37707 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, KDR, PRKCA, PTPN1, SRC, TEK |
4.30379 |
[BP] GO:2000145 |
regulation of cell motility
|
ALOX12, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
4.22671 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PRKCA, PTPN1, SRC, TEK, XDH |
4.1003 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.06466 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
4.05683 |
[BP] GO:0080134 |
regulation of response to stress
|
ALOX12, APP, CYP19A1, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.01345 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
4.00172 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
4.00172 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, EGFR, FLT3, INSR, KDR, PRKCA, PTPN1, SRC, TEK, XDH |
3.92208 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.9121 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, EGFR, IGF1R, INSR, MMP2, MMP9, NR3C1, RORC, SRC, TRPV1 |
3.9121 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.9121 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SLC5A2, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
3.90109 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ALOX12, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PRKCA, SMAD3, SRC, TEK |
3.87933 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1, TYR |
3.87933 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.87104 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, TYR |
3.87056 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, APP, AXL, CA2, CA7, CHRM1, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, MMP9, PPARA, PRKCA, PTPN1, SMAD3, SRC, TRPV1 |
3.86702 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.84141 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.84141 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.84141 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.84141 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TRPV1 |
3.82244 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AXL, CA2, CHRM3, CYP1B1, EGFR, HCAR2, HSPA1A, KDR, MET, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK, TRPV1 |
3.79192 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.77941 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.73041 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.70387 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.6834 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.67571 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, CA12, CA2, CA7, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3, TRPV1 |
3.66397 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, CDC25B, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
3.6159 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, CDC25B, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
3.6159 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.6016 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1 |
3.59969 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1, TYR |
3.59021 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, CYP1A1, CYP1B1, EGFR, FLT3, NR3C1, RORC, SRC, TRPV1 |
3.58542 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC, TEK |
3.47728 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
3.46235 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, PRKCA, SRC |
3.41182 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
3.40115 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.38874 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.37885 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.37885 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC, TEK |
3.37885 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC |
3.36706 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.36706 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, PRKCA, SRC, TEK |
3.36416 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, SRC, TRPV1 |
3.36209 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PRKCA, PTPN1, SRC, TEK, XDH |
3.33917 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC, TEK |
3.33917 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.30649 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK, XDH |
3.18358 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH |
3.17297 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
3.11942 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HSPA1A |
3.08267 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR, PRKCA |
3.06624 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3 |
3.04665 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PRKCA, PTPN1, SRC, TEK, XDH |
3.04561 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.01471 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.01471 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH |
3.01471 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PRKCA, SMAD3, SRC, TEK |
3.00232 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
2.98959 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.97512 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.97444 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.97444 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK |
2.96337 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, EGFR, FLT3, IGF1R, INSR, MMP2, NR3C1, SMAD3, SRC, TRPV1 |
2.93489 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, APP, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
2.93489 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.93489 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.93489 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.93489 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, TRPV1, XDH |
2.93241 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.91376 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH |
2.85254 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ALOX12, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, EGFR, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP9, PIM1, PRKCA, SMAD3, SRC, TEK, TRPV1, XDH |
2.84033 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, TYR |
2.84033 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.83921 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
2.83241 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.75933 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, TRPV1, XDH |
2.74798 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.74348 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.73136 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73136 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73136 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73136 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73136 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.72131 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, TYR, XDH |
2.7167 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.7167 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, PRKCA, SRC, TEK |
2.70759 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AURKB, CDC25B, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.70526 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.70524 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, SRC, TRPV1 |
2.70524 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.69075 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.65706 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.64891 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
2.64891 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, HSPA1A, KDR, MET, MMP1, PRKCA, SMAD3, SRC, TEK |
2.64891 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.63097 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.63024 |
[BP] GO:0065009 |
regulation of molecular function
|
APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
2.63024 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.59459 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.59459 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, ALOX12, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.56183 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
APP, AXL, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, TRPV1 |
2.55938 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.55831 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.53294 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.53294 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.52492 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.52492 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
2.48648 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, CDC25B, CSNK2A1, EGFR, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
2.47465 |
[BP] GO:0044057 |
None
|
CHRM1, CHRM2, CHRM3, EGFR, GPR35, HCAR2, PRKCA, SMAD3, TRPV1 |
2.46444 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.45586 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
2.40481 |
[BP] GO:0035428 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.40348 |
[BP] GO:1904659 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.40348 |
[BP] GO:1905950 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.40348 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.40334 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, EGFR, FLT3, HSPA1A, MMP9, PRKCA, RORC, SMAD3, SRC, TRPV1 |
2.40334 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, APP, AXL, CA2, CHRM1, CYP19A1, EGFR, HCAR2, INSR, SMAD3, SRC, TRPV1 |
2.38755 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AURKB, CDC25B, CSNK2A1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.38161 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.38161 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, FABP3, PPARA, SLC5A1, SLC5A2, SLC5A4, TRPV1 |
2.36013 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35549 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, ALOX15, CYP19A1, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
2.34256 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, SLC5A1 |
2.33673 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, APP, AURKB, CDC25B, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.32046 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.32046 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.32046 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.32046 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.32046 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32046 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
2.2973 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC, TEK |
2.2973 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.2973 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.28769 |
[BP] GO:0050790 |
regulation of catalytic activity
|
APP, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
2.27196 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, SRC |
2.26311 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC, TEK |
2.25192 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.24572 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, CDC25B, EGFR, FLT3, HSPA1A, INSR, KDR, MMP9, PRKCA, PTPN1, SMAD3, SRC, TEK, XDH |
2.23715 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.23715 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.23715 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTPN1, SRC, TEK |
2.22207 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, TYR |
2.21703 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.16511 |
[BP] GO:0034219 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.14905 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.14313 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.14313 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.14313 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PRKCA, PTPN1, SRC, TEK, XDH |
2.14061 |
[BP] GO:0065007 |
biological regulation
|
ACHE, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.13752 |
[BP] GO:0007193 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.13706 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.13706 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.13706 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, HSPA1A, MMP9, TRPV1, XDH |
2.13584 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DUSP3, EGFR, FLT3, IGF1R, INSR, PTPN1, SRC |
2.13312 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.12188 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, MET, MMP9, PPARA, SMAD3, SRC |
2.11496 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.08598 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.08598 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.07271 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.05125 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.05125 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.05125 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, HCAR2, KDR, SRC, TRPV1 |
2.05125 |
[BP] GO:1901655 |
None
|
AKR1B1, EGFR, NR3C1, SRC |
2.05125 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, KDR, PRKCA, TEK |
2.04488 |
[BP] GO:1903426 |
None
|
EGFR, INSR, SMAD3, TRPV1 |
2.03568 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.03568 |
[BP] GO:0003018 |
None
|
CHRM1, CHRM3, EGFR, SRC, TEK |
2.03568 |
[BP] GO:0009894 |
regulation of catabolic process
|
CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PRKCA, PTPN1, SMAD3 |
2.02749 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, CDC25B, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.01796 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.01512 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.01512 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.01512 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALOX12, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, SLC5A1, SLC5A2, SMAD3, SRC, TEK, TRPV1 |
4.19379 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC5A1, SLC5A2, SLC5A4, TEK, TRPV1 |
4.00172 |
[CC] GO:0044459 |
plasma membrane part
|
ALOX15, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DUSP3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC5A1, SLC5A2, SLC5A4, SRC, TEK, TRPV1 |
3.7579 |
[CC] GO:0005887 |
integral component of plasma membrane
|
APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC5A1, SLC5A2, SLC5A4, TEK, TRPV1 |
3.66397 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, INSR, MET, SRC, TEK, TRPV1 |
2.89756 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, SLC5A1, SLC5A2, SMAD3, SRC, TEK, TRPV1, TYR |
2.84033 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
2.71056 |
[CC] GO:0016323 |
basolateral plasma membrane
|
CA2, CA4, CA9, CHRM3, EGFR, TEK |
2.56858 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FLT3, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PTPN1, SLC5A1, SLC5A2, SLC5A4, SRC, TEK, TRPV1, TYR |
2.25974 |
[CC] GO:0030054 |
cell junction
|
ACHE, AKR1B1, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, HCAR2, HSPA1A, KDR, TEK, TRPV1 |
2.14313 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.01512 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TYR, XDH |
13.0809 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.76993 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, FLT3, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK, TYR, XDH |
9.51149 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR, XDH |
8.39533 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PRKCA, SRC, TEK, TRPV1 |
7.95615 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.34351 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.6506 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.37887 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.37887 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
6.22508 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.90848 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.64682 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.51452 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.40953 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
5.38424 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
5.24391 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.17646 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP2, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SMAD3 |
5.02827 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TRPV1, TYR, XDH |
4.78129 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
4.45862 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
4.36868 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH |
4.22671 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.19452 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.15266 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
4.04881 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.92208 |
[MF] GO:0005412 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
3.9121 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PRKCA, PTPN1, RORC, SMAD3, TRPV1, TYR, XDH |
3.80693 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, SMAD3, TEK, TRPV1 |
3.77941 |
[MF] GO:0004872 |
receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
3.73613 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
3.57899 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.51791 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 |
3.47728 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.41874 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.41874 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK |
3.3752 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.33917 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.1624 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.07664 |
[MF] GO:0099600 |
transmembrane receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
3.04059 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
3.04059 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.93489 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.93241 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1 |
2.88057 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
2.85968 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1 |
2.77068 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1 |
2.74348 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1, XDH |
2.69356 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTPN1, SRC, TEK |
2.57027 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.55831 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.55831 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.55831 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.52492 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.45586 |
[MF] GO:0005355 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.45586 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1, XDH |
2.41235 |
[MF] GO:0015149 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.40348 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, FABP3, FABP4, HSD17B1, NR3C1, PPARA, RORC, TRPV1 |
2.34953 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.32046 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.32046 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.32046 |
[MF] GO:0015145 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.32046 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.32046 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1, XDH |
2.26311 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1, XDH |
2.26193 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.23715 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.19436 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.19436 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.19436 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.14313 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.14313 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.12388 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.12388 |
[MF] GO:0004629 |
None
|
CHRM1, CHRM3, CHRM5 |
2.08598 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.05125 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCA, SRC, TEK, TRPV1 |
2.02913 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.01966 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.01512 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.01512 |